Literature DB >> 15277218

Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction.

Koichi Kaikita1, Takanori Hayasaki, Toshiyuki Okuma, William A Kuziel, Hisao Ogawa, Motohiro Takeya.   

Abstract

A key component of cardiac remodeling after acute myocardial infarction (MI) is the inflammatory response, which modulates cardiac tissue repair. The purpose of this study was to investigate the relationship between the monocytic inflammatory response and left ventricular remodeling after MI using mice deficient in CC chemokine receptor 2 (CCR2), the primary receptor for the critical regulator of CC chemokine ligand 2. Immunohistochemical analysis revealed rapid infiltration of macrophages into infarcted tissue within 7 days in wild-type (WT) mice. However, this process was greatly impaired in CCR2-deficient (CCR2(-/-)) mice. Echocardiography demonstrated beneficial effects of CCR2 deficiency on left ventricular remodeling at 7 and 28 days after MI. In situ zymography showed augmented gelatinolytic activity in WT mice within 7 days after MI, whereas gelatinolytic activity was barely detectable in CCR2(-/-) mice. Moreover, the distribution of gelatinolytic activity in serial sections was very similar to the distribution of macrophages rather than neutrophils. Expression of matrix metalloproteinases and tumor necrosis factor-alpha mRNAs was up-regulated in infarcted regions from WT mice compared to CCR2(-/-) mice at 3 days after MI. Direct inhibition of CCR2 functional pathway might contribute to the attenuation of left ventricular remodeling after MI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277218      PMCID: PMC1618584          DOI: 10.1016/S0002-9440(10)63309-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Progressive ventricular remodeling in rat with myocardial infarction.

Authors:  J M Pfeffer; M A Pfeffer; P J Fletcher; E Braunwald
Journal:  Am J Physiol       Date:  1991-05

2.  Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.

Authors:  K Ohashi; T Nemoto; K Nakamura; R Nemori
Journal:  Cancer       Date:  2000-05-15       Impact factor: 6.860

3.  Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration.

Authors:  C M Vos; S Gartner; R M Ransohoff; J C McArthur; L Wahl; L Sjulson; E Hunter; K Conant
Journal:  J Neuroimmunol       Date:  2000-09-22       Impact factor: 3.478

4.  Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.

Authors:  J T Peterson; H Li; L Dillon; J W Bryant
Journal:  Cardiovasc Res       Date:  2000-05       Impact factor: 10.787

5.  Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.

Authors:  S Heymans; A Luttun; D Nuyens; G Theilmeier; E Creemers; L Moons; G D Dyspersin; J P Cleutjens; M Shipley; A Angellilo; M Levi; O Nübe; A Baker; E Keshet; F Lupu; J M Herbert; J F Smits; S D Shapiro; M Baes; M Borgers; D Collen; M J Daemen; P Carmeliet
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

6.  Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach.

Authors:  S Takuma; K Suehiro; C Cardinale; T Hozumi; H Yano; J Shimizu; S Mullis-Jansson; R Sciacca; J Wang; D Burkhoff; M R Di Tullio; S Homma
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-05       Impact factor: 4.733

7.  Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation.

Authors:  M L Coker; J R Jolly; C Joffs; T Etoh; J R Holder; B R Bond; F G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-08       Impact factor: 4.733

Review 8.  Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?

Authors:  E E Creemers; J P Cleutjens; J F Smits; M J Daemen
Journal:  Circ Res       Date:  2001-08-03       Impact factor: 17.367

9.  Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.

Authors:  A Ducharme; S Frantz; M Aikawa; E Rabkin; M Lindsey; L E Rohde; F J Schoen; R A Kelly; Z Werb; P Libby; R T Lee
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

10.  Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion.

Authors:  M Lindsey; K Wedin; M D Brown; C Keller; A J Evans; J Smolen; A R Burns; R D Rossen; L Michael; M Entman
Journal:  Circulation       Date:  2001-05-01       Impact factor: 29.690

View more
  84 in total

Review 1.  Monocytes: protagonists of infarct inflammation and repair after myocardial infarction.

Authors:  Matthias Nahrendorf; Mikael J Pittet; Filip K Swirski
Journal:  Circulation       Date:  2010-06-08       Impact factor: 29.690

2.  Monocyte chemotactic protein-1 promotes inflammatory vascular repair of murine carotid aneurysms via a macrophage inflammatory protein-1α and macrophage inflammatory protein-2-dependent pathway.

Authors:  Brian L Hoh; Koji Hosaka; Daniel P Downes; Kamil W Nowicki; Cristina E Fernandez; Christopher D Batich; Edward W Scott
Journal:  Circulation       Date:  2011-10-17       Impact factor: 29.690

Review 3.  [Advances in cardiovascular medicine through molecular imaging].

Authors:  M Nahrendorf; R Weissleder
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

4.  Bifidobacterium animalis subsp. lactis 420 mitigates the pathological impact of myocardial infarction in the mouse.

Authors:  C A Danilo; E Constantopoulos; L A McKee; H Chen; J A Regan; Y Lipovka; S Lahtinen; L K Stenman; T-V V Nguyen; K P Doyle; M J Slepian; Z I Khalpey; J P Konhilas
Journal:  Benef Microbes       Date:  2017-04-14       Impact factor: 4.205

5.  MCP-1/CCR2 signalling pathway regulates hyperoxia-induced acute lung injury via nitric oxide production.

Authors:  Toshiyuki Okuma; Yasuhiro Terasaki; Naomi Sakashita; Koichi Kaikita; Hironori Kobayashi; Takanori Hayasaki; William A Kuziel; Hideo Baba; Motohiro Takeya
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

6.  Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart.

Authors:  Kory J Lavine; Slava Epelman; Keita Uchida; Kassandra J Weber; Colin G Nichols; Joel D Schilling; David M Ornitz; Gwendalyn J Randolph; Douglas L Mann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-27       Impact factor: 11.205

7.  Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair.

Authors:  Shirley Dehn; Edward B Thorp
Journal:  FASEB J       Date:  2017-08-31       Impact factor: 5.191

8.  Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation.

Authors:  Slava Epelman; Kory J Lavine; Anna E Beaudin; Dorothy K Sojka; Javier A Carrero; Boris Calderon; Thaddeus Brija; Emmanuel L Gautier; Stoyan Ivanov; Ansuman T Satpathy; Joel D Schilling; Reto Schwendener; Ismail Sergin; Babak Razani; E Camilla Forsberg; Wayne M Yokoyama; Emil R Unanue; Marco Colonna; Gwendalyn J Randolph; Douglas L Mann
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

9.  Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice.

Authors:  Maulik D Majmudar; Edmund J Keliher; Timo Heidt; Florian Leuschner; Jessica Truelove; Brena F Sena; Rostic Gorbatov; Yoshiko Iwamoto; Partha Dutta; Gregory Wojtkiewicz; Gabriel Courties; Matt Sebas; Anna Borodovsky; Kevin Fitzgerald; Marc W Nolte; Gerhard Dickneite; John W Chen; Daniel G Anderson; Filip K Swirski; Ralph Weissleder; Matthias Nahrendorf
Journal:  Circulation       Date:  2013-04-24       Impact factor: 29.690

10.  CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells.

Authors:  Marcin Dobaczewski; Ying Xia; Marcin Bujak; Carlos Gonzalez-Quesada; Nikolaos G Frangogiannis
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.